Yeztugo, a drug developed by Gilead, has been authorized in the United States as a preventive treatment against HIV. It requires only two injections a year, unlike current treatments that require daily pills. While the treatment could revolutionize the fight against the AIDS epidemic, cost remains a crucial issue, with an estimated annual price tag of about $25,000. UNAIDS director Winnie Byanyima emphasized the importance of making the drug affordable to have a real impact in the fight against AIDS.
Sources
Tratament promiţător împotriva HIV-SIDA. Producătorii promit prețuri accesibil
Statele Unite autorizează un nou tratament preventiv, foarte promiţător, împotriva HIV, virusul care cauzează SIDA
FDA approves first twice-yearly injection that prevents HIV infection
US approves promising preventive HIV treatment
Groundbreaking twice-a-year HIV drug that could stop transmission approved
Latest News
18:14
CNAIR announces the opening of traffic on the A1 Tigveni–Curtea de Argeș / Drivers will travel through the first highway-bored tunnel in Romania
18:04
Cristela Georgescu sent a “clarification” message regarding the postponement of the Ilfov Tribunal’s decision in her husband’s case
17:56
Constantin Toma calls for changes to the public procurement law and a reduction in bureaucracy, warning that delays are blocking local investments
17:49
Radu Oprea reaffirms Romania’s support for Ukraine and calls for increased security in the Black Sea
17:39
An AfD leader invites Elon Musk to invest in the state of Saxony-Anhalt and promises “favorable conditions for business”
See more news